Table 1 Study population
Placebo N=807 | Albendazole N=750 | |
|---|---|---|
Age (in years, mean, s.d.) | 41.9 (15.4) | 42.6 (15.5) |
Sex (female %, n/N) | 62.0 (500/807) | 59.9 (449/750) |
Body mass index (kg m−2, mean, s.d.) | 22.5 (4.0) | 22.5 (4.0) |
Leptin to adiponectin ratio (geomean (95% CI)) | 1.38 (1.25–1.53) | 1.35 (1.21–1.51) |
Leptin (ng ml−1) (geomean (95% CI)) | 7.1 (6.5–7.7) | 6.7 (6.1–7.4) |
Adiponectin (μg ml−1) (geomean (95% CI)) | 5.1 (4.9–5.4) | 5.0 (4.7–5.3) |
Resistin (ng ml−1) (geomean (95% CI)) | 15.6 (15.0–16.2) | 15.7 (15.1–16.4) |
Helminth-infected by microscopy (%, n/N) | 43.5 (270/620) | 40.5 (233/575) |
Single species | 28.2 (175/620) | 26.4 (152/575) |
Multiple species | 15.3 (95/620) | 14.1 (81/575) |
Helminth-infected by PCR (%, n/N) | 53.8 (392/729) | 54.4 (368/676) |
Single species | 31.7 (231/729) | 35.2 (238/676) |
Multiple species | 22.1 (161/729) | 19.2 (130/676) |
